Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local cortone injection for post-root canal pain in irreversible pulpitis
IRCT2016053028173N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cortisone in irreversible pulpitis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Post-treatment pain perception. Started Aug 2016; status: completed.
02
Drugs
cortisone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT2016053028173N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016053028173N2.